| 1 |
Mohapatra RK, Verma S, Kandi V, Sarangi AK, Seidel V, Das SN, Behera A, Tuli HS, Sharma AK, Dhama K. The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review. ChemistrySelect 2023;8. [DOI: 10.1002/slct.202201380] [Reference Citation Analysis]
|
| 2 |
Cox M, Peacock TP, Harvey WT, Hughes J, Wright DW, Willett BJ, Thomson E, Gupta RK, Peacock SJ, Robertson DL, Carabelli AM; COVID-19 Genomics UK (COG-UK) Consortium. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat Rev Microbiol 2023;21:112-24. [PMID: 36307535 DOI: 10.1038/s41579-022-00809-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 3 |
Wurtz N, Boussier M, Souville L, Penant G, Lacoste A, Colson P, La Scola B, Aherfi S. Simple Wastewater Preparation Protocol Applied to Monitor the Emergence of the Omicron 21L/BA.2 Variant by Genome Sequencing. Viruses 2023;15. [PMID: 36851484 DOI: 10.3390/v15020268] [Reference Citation Analysis]
|
| 4 |
Suardana IBK, Mahardika BK, Pharmawati M, Sudipa PH, Sari TK, Mahendra NB, Mahardika GN. Whole-Genome Comparison of Representatives of All Variants of SARS-CoV-2, Including Subvariant BA.2 and the GKA Clade. Adv Virol 2023;2023:6476626. [PMID: 36938489 DOI: 10.1155/2023/6476626] [Reference Citation Analysis]
|
| 5 |
Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, Zhou H, Islam MR, Mamada SS, Kusuma HI, Rabaan AA, Alhumaid S, Mutair AA, Iqhrammullah M, Al-Tawfiq JA, Mohaini MA, Alsalman AJ, Tuli HS, Chakraborty C, Harapan H. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4-14. [PMID: 36446204 DOI: 10.1016/j.jiph.2022.11.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 6 |
Roohani J, Keikha M. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned? World J Virol 2022; 11(6): 496-501 [DOI: 10.5501/wjv.v11.i6.496] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Phan T, Boes S, McCullough M, Gribschaw J, Wells A. Mini-evaluation of the Lyra SARS-CoV-2 assay to detect Omicron BA.1 and BA.2 in nasopharyngeal swabs. J Clin Virol Plus 2022;2:100118. [PMID: 36277996 DOI: 10.1016/j.jcvp.2022.100118] [Reference Citation Analysis]
|
| 8 |
Rahman S, Hossain MJ, Nahar Z, Shahriar M, Bhuiyan MA, Islam MR. Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic. Environ Health Insights 2022;16:11786302221129396. [PMID: 36299441 DOI: 10.1177/11786302221129396] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Bedada FB, Gorfu G, Teng S, Neita ME. Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options. Front Mol Med 2022;2. [DOI: 10.3389/fmmed.2022.917201] [Reference Citation Analysis]
|
| 10 |
Chadeau-Hyam M, Tang D, Eales O, Bodinier B, Wang H, Jonnerby J, Whitaker M, Elliott J, Haw D, Walters CE, Atchison C, Diggle PJ, Page AJ, Ashby D, Barclay W, Taylor G, Cooke G, Ward H, Darzi A, Donnelly CA, Elliott P. Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys. Lancet Reg Health Eur 2022;21:100462. [PMID: 35915784 DOI: 10.1016/j.lanepe.2022.100462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Laine L, Skön M, Väisänen E, Julkunen I, Österlund P. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant. Front Immunol 2022;13:1016108. [DOI: 10.3389/fimmu.2022.1016108] [Reference Citation Analysis]
|
| 12 |
Li J, Gao Z, Chen J, Cheng R, Niu J, Zhang J, Yang Y, Yuan X, Xia J, Mao G, Liu H, Dong Y, Wu C. Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2. Front Cell Infect Microbiol 2022;12:953027. [DOI: 10.3389/fcimb.2022.953027] [Reference Citation Analysis]
|
| 13 |
Sánchez-morales L, Sánchez-vizcaíno JM, Pérez-sancho M, Domínguez L, Barroso-arévalo S. The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals. Front Vet Sci 2022;9:940710. [DOI: 10.3389/fvets.2022.940710] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Aoki A, Adachi H, Mori Y, Ito M, Sato K, Okuda K, Sakakibara T, Okamoto Y, Jinno H. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study. Microbiol Spectr 2022;:e0136722. [PMID: 35861527 DOI: 10.1128/spectrum.01367-22] [Reference Citation Analysis]
|
| 15 |
Ghazvini K, Keikha M. What we recognize about omicron sub-lineage BA.2 as a global new challenge? - Correspondence. Int J Surg 2022;103:106704. [PMID: 35697323 DOI: 10.1016/j.ijsu.2022.106704] [Reference Citation Analysis]
|
| 16 |
Li Y, Polotan FGM, Sotelo GIS, Alpino APA, Dolor AYM, Tujan MAA, Gomez MRR, Onza OJT, Chang AKT, Bautista CT, Carandang JC, Lim DR, Dancel LLM, Uy-lumandas M, Dizon TJR, Hampson K, Daldry S, Hughes J, Brunker K. Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines.. [DOI: 10.1101/2022.05.30.22275783] [Reference Citation Analysis]
|
| 17 |
Hrzic R, Peixoto VR, Mason-Jones AJ, McCallum A; ASPHER COVID-19 Task Force. Is it really time to ditch the mask? BMJ 2022;377:o1186. [PMID: 35545285 DOI: 10.1136/bmj.o1186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Marathe SD, Shamanna V, Nagaraj G, Nischita S, Bhaskaran M, Ravikumar KL. Whole-Genome Sequencing Of Omicron Identified Multiple Outbreaks And Introduction Events In India During November 2021 and January 2022.. [DOI: 10.1101/2022.04.20.22270880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Loconsole D, Centrone F, Sallustio A, Accogli M, Casulli D, Sacco D, Zagaria R, Morcavallo C, Chironna M. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January–March 2022. Vaccines 2022;10:674. [DOI: 10.3390/vaccines10050674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Sánchez-morales L, Sánchez-vizcaíno JM, Pérez-sancho M, Domínguez L, Barroso-arévalo S. The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals.. [DOI: 10.1101/2022.04.13.488132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Aoki A, Adachi H, Mori Y, Ito M, Sato K, Okuda K, Sakakibara T, Okamoto Y, Jinno H. Discrimination of SARS-CoV-2 Omicron sub-lineages BA.1 and BA.2 using a high-resolution melting-based assay: A pilot study.. [DOI: 10.1101/2022.04.11.487970] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 22 |
Hirotsu Y, Maejima M, Shibusawa M, Natori Y, Nagakubo Y, Hosaka K, Sueki H, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M. Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.. [DOI: 10.1101/2022.04.03.22273268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 23 |
Lentini A, Pereira A, Winqvist O, Reinius B. Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 variant transition in the Swedish population reveals higher viral quantity in BA.2 cases.. [DOI: 10.1101/2022.03.26.22272984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 24 |
Erster O, Kabat A, Asraf H, Levy V, Mannasse B, Azar R, Nemet I, Kliker L, Fleishon S, Mandelboim M, Mendelson E, Zuckerman NS. NOVEL RT-qPCR ASSAYS ENABLE RAPID DETECTION AND DIFFERENTIATION BETWEEN SARS-COV-2 OMICRON (BA.1) AND BA.2 VARIANTS.. [DOI: 10.1101/2022.02.22.22271222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Ito K, Piantham C, Nishiura H. . MBE 2022;19:9005-17. [DOI: 10.3934/mbe.2022418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 26 |
王 康. Research Progress of SARS-CoV-2 Omicron Variant. AMB 2022;11:49-60. [DOI: 10.12677/amb.2022.112006] [Reference Citation Analysis]
|
